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Conclusions: Ablation of frequent PVCs improves cardiac function, especially for
patients with LV dysfunction.
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Objectives: Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting
enzyme in regenerating nicotinamide adenine dinucleotide (NAD+) from nicotin-
amide. NAMPT has crucial roles for myocardial development, cardiomyocyte
energy metabolism and cell death/survival by regulating NAD+-dependent sirtuin-1
deacetylase. Serum NAMPT also functions as a potential inﬂammatory cytokine in
diverse biological contexts. The purpose of this study was to clarify the hypothesis
that SNPs of the NAMPT gene may affect the susceptibility and prognosis for DCM
patients and to describe the association of NAMPT expression with clinical features
of DCM.
Methods: Three SNPs of NAMPT, including rs61330082 in the promoter
region, rs2505568 and rs9034 in the 30untranslated region were genotyped by
polymerase chain reaction-restriction fragment length polymorphism method in 394
patients with DCM and 395 controls. Plasma NAMPT levels of 113 DCM patients and
137 controls were measured using commercial ELISA kits.
Results: Statistically signiﬁcant decreased DCM risk was found to be associated
with the A allele and AT genotype of rs2505568 (OR 0.48, 95% CI 0.35-0.67,
P<0.0001 and OR 0.44, 95% CI ¼0.31-0.62, P<0.0001 respectively). Rs9034 C
allele and CC genotype were also associated with decreased DCM risk
(OR 0.61, 95% CI 0.44-0.86, P¼0.005 and OR 0.58, 95% CI 0.40-0.83, P¼0.0027
respectively). There was no difference of the allele and genotype frequencies
of rs61330082 polymorphism between DCM and control groups. The rs9034 CT
genotype presented longer overall survival than CC genotype in both univariable
(HR: 0.59, 95% CI 0.39-0.89, P¼0.01) and multivariable survival analysis after
adjusting for age and sex (HR: 0.56, 95% CI 0.37-0.86, P¼0.007). NAMPT
expression was signiﬁcantly higher in the DCM group compared with controls
(6.69 4.97 and 3.711.21 ng/ml, P<0.0001) but not associated with 3 SNPs.
There were signiﬁcant increases of NAMPT levels in NYHA IV class group than
NYHA II/III class group and the controls (10.676.23, 4.592.17 and 3.711.21
ng/ml, all P<0.0001). The NAMPT levels in NYHA II/III class group were
signiﬁcantly increased compared to controls (4.592.17 and 3.711.21 ng/ml,
P¼0.005).
A signiﬁcant correlation between NAMPT levels and N-terminal pro brain natri-
uretic hormone (r ¼ 0.726, P<0.0001) was found. We also observed a signiﬁcant
correlation between NMAPT levels and left ventricular end-diastolic diameter
(r ¼ 0.296, P¼0.01) and left ventricular end-diastolic volume (r ¼ 0.294, P¼0.011).
There were no correlations between NAMPT levels and left ventricular stroke volume,
ejection fraction and fractional shortening (r ¼ 0.10, P¼0.39; r ¼ -0.107, P¼0.362;
r ¼ 0.027, P¼0.85).
Conclusions: SNPs of NAMPT might be a novel genetic biomarker for the risk and
prognosis of DCM. NAMPT expression was associated with the degree of heart
failure and the features of echocardiography in DCM patients. Our Results suggested
an important role for NAMPT in the pathogenesis of DCM.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e3420
Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic
markers of survival in hospitalized patients with dilated cardiomyopathy: a
single-center cohort study
Li Xiaoping1, Chengzhi Chen1,2, Feng Gan1,3, Yang Wang1, Ligang Ding1, Wei Hua1
1Cardiac Arrhythmia Center, State Key Laboratory of Cardiovascular Disease, Fuwai
Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical
Sciences and Peking Union Medical College, Beijing, 100037, China, 2Department of
Cardiology, Liuyang People Hospital, Liuyang, 421001, China, 3Department of
Cardiology, Beijing Aerospace General Hospital, Beijing, 100037, China
Objectives: Circulating N-terminal pro-B-type natriuretic peptide (NT pro-BNP), high-
sensitivity C-reactive protein (hs-CRP) and big endothelin (big-ET) have been shown to be
increased in heart failure and to contribute to both hemodynamic deterioration and cardio-
vascular remodeling. Here, we examined the prognostic value of the three neurohormones
at admission in a population of hospitalized patients with dilated cardiomyopathy (DCM).
Methods: This cohort study was undertaken in 622 hospitalized patients with DCM in
Fuwai Hospital from January 2005 to September 2011 (female 26.5%, 51.414.6
years old). Standard demographics, echocardiography and routine blood samples were
obtained shortly after admission. NT pro-BNP, hs-CRP and big-ET were measured,
and their concentrations in relation to all-cause mortality were assessed through a
mean follow-up of 2.61.6 years.
Results: Kaplan-Meier curves showed that the all-cause mortality rates were higher in
patients with NT pro-BNP>2247 pmol/L compared to patients with NT pro-
BNP<2247 pmol/L (11.9% vs 34.8%, log-rank c2¼35.588, P<0.001), in patients
with hs-CRP>3.90 mg/L compared to patients with hs-CRP<3.90 mg/L (12.8% vs
33.6%, log-rank c2¼39.662, P<0.001) and in patients with big-ET>0.95 pmol/L
compared to patients with big-ET <0.95 pmol/L (12.5% vs 31.0%, log-rank
c2¼17.890, P<0.001) . High circulating concentrations of NT pro-BNP (HR 2.217,
95% CI 1.015-4.846, P¼0.046) and hs-CRP (HR 1.922, 95% CI 1.236-2.988,
P¼0.004), but not big-ET, in addition to left atrial diameter and fasting blood glucose,
were independent predictors of the outcome deﬁned as all-cause mortality.
Conclusions: In a large population of patientswithDCM, the circulating concentrations of
NTpro-BNPandhs-CRP, but not big-ET,were independentmarkers of all-causemortality.
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Objectives: To analyze and summarise the characters of echocardiographic myocar-
dial mechanics in Chinese patients with cardiac involvement due to primary
amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) using transthoracic
echocardiography (TTE) with 2-dimensional velocity vector imaging (VVI) .
Methods: 30 patients with biopsy-proved conﬁrmed AL-cardiac amyloidosis, 30
patients with asymmetric hypertrophic cardiomyopathy and 30 age-matched healthy
volunteers were included in the study. The clinical characteristics were collected and
three groups underwent conventional TTE and VVI. TTE was used for the evaluation
of LV wall thickness, left atrial and ventricle size, systolic and diastolic function. VVI
was used for the evaluation of LV segments and walls endocardial (ENDO),
myocardial (MYO) and epicardial (EPI) longitudinal, circumferential and radial strain
(LS, CS and RS). AL-CA and HCM patients also underwent cardiac magnetic reso-
nance (CMR) to evaluate the late gadolinium enhancement (LGE) features.
Results: There were no statistic differences in clinical symptoms and physical signs
between AL-CA andHCMgroups. LVwall thickness, LA diameter, E/A ratio, Septal E/
e’ ratio and the prevalence of granular sparklingwere higher in bothAL-CA andHCM in
comparison with controls (P<0.001), but ejection fraction (EF) was lower in patients
with AL-CA in comparison with HCM and controls (40.47.8%, 56.65.5%,
604.0%, respectively). LV ENDO LS, ENDO CS and RS in 16 segments were
signiﬁcantly lower inAL-CAwhen comparedwithHCMand controls, however, LVEPI
LS, EPI CS in apical and mid segments were similar among patients with AL-CA, HCM
and controls. The difference between ENDO and EPI LS (ENDO-EPI LS) in all left
ventricle walls were signiﬁcantly lower in AL-CA in comparison with controls, how-
ever, those changes in HCMwere variable. The LGE of CMR also showed the different
features in AL-CA and HCM: AL-CA group showed subendocardial LGE almost in all
LV walls, but HCM group showed patchy LGE in a regional, multifocal distribution.
Conclusions: AL-CA is characterised by a remarkable reduction of ENDO LS, CS
and RS in LV segments and an uniform decrease of ENDO-EPI LS in all LV walls,
but the changes in HCM is variable.
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